Latest Auditor Review News

8I Holdings Limited has reported a remarkable 255% surge in net profit for the half-year ending September 2025, yet it has chosen not to declare any dividends. Investors are left weighing strong gains against cautious capital management.

Income Asset Management has resumed ASX trading after revealing a $1.5 million fraud involving a former employee, while assuring clients their assets remain secure under current custodianship.

Platformo Ltd reported a 38% revenue increase driven by its Malaysian software arm Biztrak, alongside a modest improvement in its half-year loss. The company continues to navigate regulatory shifts and product enhancements in a competitive software market.

BDO Audit has completed its review of HeraMED Limited’s half-year financial report for June 2025, confirming compliance with accounting standards but highlighting significant uncertainty over the company’s ability to continue as a going concern.

Vita Life Sciences reported a robust half-year performance with revenue up 15.4% to A$45.5 million and a 12.2% rise in net profit, driven by strong growth in Australia and Southeast Asia. The company also increased its interim dividend to 4.5 cents per share, signaling confidence despite challenges in China.

Reckon Limited has delivered a robust half-year performance with a 16% revenue increase and a 29% rise in net profit attributable to members, while declaring a steady fully franked dividend. Despite these gains, the company’s net tangible assets per share remain negative, highlighting ongoing balance sheet pressures.

Waypoint REIT’s half-year update reveals a 3.4% portfolio valuation increase to $2.89 billion, alongside a strategic pause in its $50 million buyback program after $32.9 million in purchases.

Regal Partners estimates at least $35 million in performance fee revenue for the first half of 2025, driven by strong global equity strategies and diverse alternative funds. The full half-year results will be released on 25 August.

Nufarm Finance (NZ) Limited reported a 4.1% increase in net profit after tax to NZD 10.35 million for the half-year ended 31 March 2025, driven by higher interest rates. The company declared an interim distribution of NZD 4.31 per security, payable in October 2024.

Big River Industries reported a significant $17 million loss for the half-year ending December 2024, driven by a $20 million non-cash impairment charge and a 3.3% revenue decline. The company also announced a reduced fully franked interim dividend of 2 cents per share.

Mayne Pharma reports a robust first half of FY25 with revenues climbing to $210-$215 million and underlying EBITDA soaring by up to 300%, driven by strong performance in Women's Health.

PEXA Group Limited has updated its half-year guidance, flagging a $15 million non-cash impairment and a significant increase in tax expenses due to deferred tax asset derecognition.